Show the Real-World Impact of Your Therapy - With the Outcomes That Matter Most

Patient-Centered Research Solutions for Life Sciences

How it works

We offer a comprehensive, end-to-end research solution for complex, heterogeneous conditions, including:

Dedicated research and analysis team
Protocol design & approval
Multi-channel recruitment, e-consent, enrollment
Validated ePRO deployment that complements HROs
Data stewardship & hosting
Linkage to EMR, claims, wearables, and registry data
Data analysis and reporting
Thought partnership for scientific communications and publications

Customer Perspectives:

My programs often struggle with the fact that traditional clinical endpoints do not demonstrate the full value of the therapy, and we experience a disconnect about endpoints needed for Approval vs. for Reimbursement.

Vice President, HEOR (Neurology Biotech)

This gives you insight that you don’t get from PROs and does not rely on long recall period. To me, that is the interesting nuance.

Executive Director, WW HEOR RWD (Top 10 Pharma)

publications

DEMO request

We offer a suite of patient-driven outcomes solutions built for life sciences,
from early clinical development to therapy commercialization:

Natural History

Burden

Impact

explore case studies

white paper: payer, provider, and patient communications

Why Life Sciences Innovators Choose Folia

Solve common RWD dataset challenges:

Identify, characterize, and measure change in currently undetected flare events
Measure disease heterogeneity and discover phenotypes that drive how patients do on therapy
Understand treatment use, including “Why not?” reasons and missing doses/switching medications

Patient-driven, high fidelity, and high value insights:

Discover the full scope of patient priorities & how your therapy impacts them
Reduce responder burden with questions that are relevant to each participant’s journey
Drive value to the patient with built-in patient data return